Literature DB >> 843988

Metergoline as a selective 5-hydroxytryptamine antagonist in the cerebral cortex.

B S Sastry, J W Phillis.   

Abstract

In rats anaesthetized with a mixture of methoxyflurane, nitrous oxide, and oxygen, the depressant actions on the cerebral cortical neurones of iotophoretically applied 5-hydroxytryptamine (5-HT) but not of noradrenaline, histamine, AMP Ca2+, and gamma-aminobutyric acid were antagonized by metergoline. These observations indicate that metergoline may be a selective 5-HT antagonist in the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843988     DOI: 10.1139/y77-020

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  19 in total

1.  High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.

Authors:  P M Whitaker; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

2.  A possible serotoninergic link in the hypothermic action of histamine [proceedings].

Authors:  A Pilc; J Z Nowak
Journal:  Agents Actions       Date:  1979-04

3.  Evidence for selective serotonergic receptor involvement in p-chloroamphetamine-induced antinociception.

Authors:  S O Ogren; O G Berge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

4.  Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex.

Authors:  M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

5.  Metergoline elevates or reduces nociceptive thresholds in mice depending on test method and route of administration.

Authors:  O B Fasmer; O G Berge; K Hole
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Improved oral glucose tolerance following antiserotonin treatment in patients with chemical diabetes.

Authors:  C Ferrari; C Barbieri; R Caldara; V Magnoni; G P Testori; M Romussi
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

7.  A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212).

Authors:  B V Clineschmidt; J C McGuffin; A B Pflueger; J A Totaro
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

8.  Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.

Authors:  I Lemaire; R Tseng; S Lemaire
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

9.  Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker.

Authors:  S Bourgoin; F Artaud; J Bockaert; F Héry; J Glowinski; M Hamon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

10.  Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?

Authors:  R Invernizzi; K Kmieciak-Kolada; R Samanin
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.